A novel approach to inhibit HIV-1 infection and enhance lysis of HIV by a targeted activator of complement (Q39403858)

11 September 2017

A novel approach to inhibit HIV-1 infection and enhance lysis of HIV by a targeted activator of complement (English)

1 reference

11 September 2017

Yuanyong Xu

1

1 reference

11 September 2017

Chuanfu Zhang

2

1 reference

11 September 2017

Leili Jia

3

1 reference

11 September 2017

Cuirong Wen

4

1 reference

11 September 2017

Huihui Liu

5

1 reference

11 September 2017

Yong Wang

6

1 reference

11 September 2017

Yansong Sun

7

1 reference

11 September 2017

Liuyu Huang

8

1 reference

11 September 2017

Yusen Zhou

9

1 reference

11 September 2017

Hongbin Song

10

1 reference

11 September 2017

language of work or name

1 reference

12 August 2009

1 reference

11 September 2017

1 reference

11 September 2017

6

1 reference

11 September 2017

123

1 reference

https://scigraph.springernature.com/pub.10.1186/1743-422x-6-123

11 September 2017

0 references

cites work

Humoral immunity to HIV-1: neutralisation and antibody effector functions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224960

Traitors of the immune system-enhancing antibodies in HIV infection: their possible implication in HIV vaccine development

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224960

Complement-HIV interactions during all steps of viral pathogenesis.

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224960

HIV and human complement: inefficient virolysis and effective adherence.

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224960

Complement-opsonized HIV: the free rider on its way to infection

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224960

AIDS vaccine fails in Thai trial

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224960

Follicular dendritic cell contributions to HIV pathogenesis

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224960

Comparison of human immunodeficiency virus (HIV)-specific infection-enhancing and -inhibiting antibodies in AIDS patients

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224960

The supportive role of complement in HIV pathogenesis

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224960

Complement. Second of two parts

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224960

Persistence of infectious HIV on follicular dendritic cells

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224960

B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224960

Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55).

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224960

Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224960

Detachment of human immunodeficiency virus type 1 from germinal centers by blocking complement receptor type 2.

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224960

Mechanism for complement-mediated, antibody-dependent enhancement of human immunodeficiency virus type 1 infection in MT2 cells is enhanced entry through CD4, CD21, and CXCR4 chemokine receptors

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224960

Acquisition of host cell-surface-derived molecules by HIV-1.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224960

Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224960

Fc receptor but not complement binding is important in antibody protection against HIV.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224960

Host cell components affect the sensitivity of HIV type 1 to complement-mediated virolysis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224960

A human immunodeficiency virus type 1 (HIV-1) infection-enhancing factor in seropositive sera

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224960

Antibody-dependent enhancement of human immunodeficiency virus type 1 infection

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224960

Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224960

B cell-mediated infection of stimulated and unstimulated autologous T lymphocytes with HIV-1: role of complement

21 August 2018

1 reference

12 December 2020

HIV vaccine fails in phase 3 trial

1 reference

12 December 2020

Mechanism(s) promoting HIV-1 infection of primary unstimulated T lymphocytes in autologous B cell/T cell co-cultures

1 reference

12 December 2020

Complement dependent trapping of infectious HIV in human lymphoid tissues

1 reference

12 December 2020

Factor I-Mediated Processing of Complement Fragments on HIV Immune Complexes Targets HIV to CR2-Expressing B Cells and Facilitates B Cell-Mediated Transmission of Opsonized HIV to T Cells

1 reference

12 December 2020

Role for CD21 in the establishment of an extracellular HIV reservoir in lymphoid tissues

1 reference

12 December 2020

AIDS research. Promising AIDS vaccine's failure leaves field reeling

1 reference

12 December 2020

Identifiers

DOI

10.1186/1743-422X-6-123

1 reference

Dimensions Publication ID

11 September 2017

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1743-422x-6-123

1 reference

11 September 2017

PubMed publication ID

19671191

1 reference